Blood filtering therapy for sepsis
Part of Infections clinical trials.
This study tests a blood-filtering treatment that may help remove harmful substances from the blood in people with sepsis. It might improve recovery for patients in the intensive care unit (ICU).
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years old or older.
- You must have sepsis, a severe infection that affects your whole body.
- Your blood test must show a high level of a protein called IL-6 (more than 100 pg/mL).
- You are expected to stay in the ICU for more than 48 hours.
- You must not have a weakened immune system (from medications or HIV).
- You must not have severe bleeding problems (like very low platelets or abnormal clotting tests).
- You must not have chronic kidney disease or kidney failure.
- You must not be pregnant or breastfeeding.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial looks at whether a blood-filter treatment (called “AN69ST Verse PS” using a hemofilter) can help children with early, serious sepsis and poor circulation or organ problems. It may help stabilize the body faster, but eligibility is limited to certain sepsis situations and recent timing.
This study tests whether a blood purification treatment can help children with severe sepsis (a life-threatening infection) by filtering their blood to remove harmful substances. It may help improve organ function and recovery.
This trial tests a special blood filtering device (OXiris) in patients with severe abdominal infections and septic shock. The filter may help remove harmful substances from the blood and support kidney function, potentially improving recovery.
This trial tests a blood-filtering treatment for people in septic shock, a severe reaction to infection. It aims to see if removing harmful substances from the blood can help recovery.
This trial tests a blood-filtering device (CytoSorb) that may help control the overwhelming immune response and improve blood vessel function in people with severe septic shock. It's for patients who need strong medications to keep their blood pressure up and who haven't improved with standard care.
This trial tests a special blood-filtering method (adaptive blood purification) for people with septic shock caused by a severe infection. It aims to see if this treatment can help control inflammation and improve recovery in the ICU.
Hear when a new Sepsis and Septic Shock trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.